Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
Pharmacokinetic properties and metabolism of idebenone.
Immunology 2014
Colestipol May Quickly Eliminate Teriflunomide
Imaging outcomes for trials of remyelination in multiple sclerosis.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Predictive value of early brain atrophy on response in patients treated with interferon β.
Daclizumab for relapsing remitting multiple sclerosis.
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
Treatment of acute transverse myelitis and its early complications.
Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease.
Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis
Long-Term Safety and Efficacy Study of BIIB017 (PEGylated Interferon Beta-1a) (ATTAIN)
Study to evaluate early glatiramer acetate treatment in delaying conversion to CDMS of subjects presenting with CIS (PreCISe)
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Estimating Time to Disease Progression Comparing Transition Models and Survival Methods-An Analysis of Multiple Sclerosis Data.
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.
Rituximab Use in Pediatric Central Demyelinating Disease.
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.

Pages